Dr. Divpreet Kaur, MD

Dr. Kaur practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Kaur's NPI, 1457580409, was assigned on July 13, 2009. Dr. Kaur holds Pennsylvania license MD449106.

Dr. Kaur's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Dr. Kaur's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. Dr. Kaur is also affiliated with WellSpan York Hospital. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Kaur to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaur practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kaur's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kaur is licensed in Pennsylvania.

CMS data shows 330 Medicare services from Dr. Kaur across 6 procedure codes in 2024, for 193 Medicare patients. Medicare paid $16,862 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 193 Medicare patients who saw Dr. Kaur in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaur's median patient age at 68, with 56% women.

In 2024, Dr. Kaur wrote 491 Medicare Part D claims for 67 patients. 71% of them were for generic drugs. CMS names the drug for 395 of them, across 12 drugs with 11 or more claims each, at $1,701,993 in total drug cost. In 2023, CMS named 376 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Kaur for performance year 2024, reported as part of a group. Dr. Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Kaur, published from 2016 to 2025. 2016 was the busiest year, with 3. Dr. Kaur has published most often in Mol Divers. Dr. Kaur's most frequent co-authors are Puneet Singh Kochar, MD, Robert Harris Baloh, MD, PhD and Robert William Baloh, MD.

CMS Open Payments shows 8 general payments to Dr. Kaur from 7 drug and device companies from 2017 to 2021. Food and beverage make up the largest share, 95% of the total. Alnylam Pharmaceuticals Inc. paid the most, $96.